https://www.ucb-usa.com/ 2026-03-05T18:49:21+00:00 daily 1.0 https://www.ucb-usa.com/node/1 2026-03-05T18:49:21+00:00 0.5 https://www.ucb-usa.com/Careers/Applying-to-UCB-UK 2020-04-08T14:05:25+01:00 0.5 https://www.ucb-usa.com/Patients/contact_form 2024-12-19T16:04:09+00:00 0.5 https://www.ucb-usa.com/sitemap 2023-02-09T19:25:26+00:00 0.5 https://www.ucb-usa.com/node/41 2020-02-19T15:23:54+00:00 0.5 https://www.ucb-usa.com/UCB-in-the-U-S/UCB-in-the-US 2025-12-16T16:38:54+00:00 0.5 https://www.ucb-usa.com/UCB-in-the-U-S/U-S-Leadership-Team 2025-05-21T10:11:55+01:00 0.5 https://www.ucb-usa.com/UCB-in-the-U-S/U-S-Leadership-Team/Armelle-Blanchet 2022-04-07T21:31:25+01:00 0.5 https://www.ucb-usa.com/UCB-in-the-U-S/U-S-Leadership-Team/Mike-Davis 2022-01-21T14:00:10+00:00 0.5 https://www.ucb-usa.com/UCB-in-the-U-S/U-S-Leadership-Team/Anisa-Dhalla 2024-07-22T15:51:06+01:00 0.5 https://www.ucb-usa.com/UCB-in-the-U-S/U-S-Leadership-Team/Patty-Fritz 2025-05-28T18:29:30+01:00 0.5 https://www.ucb-usa.com/UCB-in-the-U-S/U-S-Leadership-Team/Camille-Lee 2025-05-28T18:28:02+01:00 0.5 https://www.ucb-usa.com/UCB-in-the-U-S/U-S-Leadership-Team/Kim-Moran 2025-10-22T21:26:04+01:00 0.5 https://www.ucb-usa.com/Patients 2025-11-21T22:23:53+00:00 0.5 https://www.ucb-usa.com/Patients/U-S-Clinical-Trials 2025-10-22T18:27:47+01:00 0.5 https://www.ucb-usa.com/Innovation/Products 2025-10-23T19:48:23+01:00 0.5 https://www.ucb-usa.com/responsibility/ethicalbusinesspractices 2025-06-30T19:43:40+01:00 0.5 https://www.ucb-usa.com/Responsibility/Transparency 2025-04-16T10:00:34+01:00 0.5 https://www.ucb-usa.com/Responsibility/U-S-Policy 2025-10-22T21:51:48+01:00 0.5 https://www.ucb-usa.com/Innovation/Products/Briviact 2025-07-02T21:13:52+01:00 0.5 https://www.ucb-usa.com/Innovation/Products/Cimzia 2025-07-02T21:08:51+01:00 0.5 https://www.ucb-usa.com/Innovation/Products/Nayzilam 2025-07-02T21:17:14+01:00 0.5 https://www.ucb-usa.com/Innovation/Products/Neupro 2025-07-02T21:29:10+01:00 0.5 https://www.ucb-usa.com/Innovation/Products/Vimpat 2025-07-02T21:35:31+01:00 0.5 https://www.ucb-usa.com/Innovation/U-S-Innovation 2025-10-22T21:44:00+01:00 0.5 https://www.ucb-usa.com/Innovation/Pipeline 2025-04-16T09:26:40+01:00 0.5 https://www.ucb-usa.com/Healthcare-Professionals 2026-01-23T18:03:45+00:00 0.5 https://www.ucb-usa.com/Legal 2020-06-02T08:48:50+01:00 0.5 https://www.ucb-usa.com/policy 2026-03-03T10:56:06+00:00 0.5 https://www.ucb-usa.com/Contact/Contact-Us 2025-12-16T16:42:10+00:00 0.5 https://www.ucb-usa.com/Responsibility/U-S-Policy/Innovation 2022-06-28T18:17:25+01:00 0.5 https://www.ucb-usa.com/Responsibility/U-S-Policy/Value-Based-Care 2022-06-28T18:20:12+01:00 0.5 https://www.ucb-usa.com/Responsibility/U-S-Policy/Affordable-Access 2022-07-29T19:00:43+01:00 0.5 https://www.ucb-usa.com/Responsibility/Affordability/Nayzilam-Pricing-Info 2026-01-07T19:18:49+00:00 0.5 https://www.ucb-usa.com/stories-media/Newsroom 2025-12-16T16:41:30+00:00 0.5 https://www.ucb-usa.com/stories-media/UCB-U-S-News 2022-04-05T16:48:36+01:00 0.5 https://www.ucb-usa.com/stories-media/Media-Contact 2025-12-16T16:47:49+00:00 0.5 https://www.ucb-usa.com/stories-media/Speakers 2025-04-16T10:18:27+01:00 0.5 https://www.ucb-usa.com/stories-media/UCB-U-S-News/Form 2020-06-19T09:20:13+01:00 0.5 https://www.ucb-usa.com/Patients/Financial-Assistance 2026-02-05T06:40:00+00:00 0.5 https://www.ucb-usa.com/Healthcare-Professionals/Report-an-Adverse-Event 2026-01-23T18:04:33+00:00 0.5 https://www.ucb-usa.com/Patients/California-Consumer-Privacy-Act 2026-03-03T10:50:06+00:00 0.5 https://www.ucb-usa.com/site-search 2020-06-11T11:55:49+01:00 0.5 https://www.ucb-usa.com/affordability 2026-03-06T21:01:42+00:00 0.5 https://www.ucb-usa.com/Responsibility/Affordability/Briviact-Pricing-Info 2026-01-07T18:04:25+00:00 0.5 https://www.ucb-usa.com/Responsibility/Affordability/Cimzia-Pricing-Info 2026-01-07T18:14:09+00:00 0.5 https://www.ucb-usa.com/cookie-policy 2021-06-22T16:23:55+01:00 0.5 https://www.ucb-usa.com/Disease-Areas/Dermatology 2025-04-16T09:31:25+01:00 0.5 https://www.ucb-usa.com/FerringMedicalWebform 2020-08-24T14:19:10+01:00 0.5 https://www.ucb-usa.com/UCB-in-the-U-S/US-PharmD-Fellowships 2025-09-03T01:01:55+01:00 0.5 https://www.ucb-usa.com/Responsibility/US-Advocacy-Principles 2025-04-16T10:08:21+01:00 0.5 https://www.ucb-usa.com/Innovation/Digital-Business-Transformation 2025-04-16T09:24:26+01:00 0.5 https://www.ucb-usa.com/Sustainability/inclusion-at-UCB 2025-11-05T21:12:13+00:00 0.5 https://www.ucb-usa.com/Disease-Areas/Rare-Diseases 2025-04-16T09:35:50+01:00 0.5 https://www.ucb-usa.com/UCB-in-the-U-S/U-S-Leadership-Team/Jane-Thompson 2024-08-07T02:39:16+01:00 0.5 https://www.ucb-usa.com/innovation/axspa-id-query-set 2023-09-13T22:21:23+01:00 0.5 https://www.ucb-usa.com/UCB-in-the-U-S/U-S-Leadership-Team/Simon-Lemmy 2023-04-28T14:57:45+01:00 0.5 https://www.ucb-usa.com/sustainability/U-S-transparency-report 2023-03-15T12:40:52+00:00 0.5 https://www.ucb-usa.com/sustainability 2025-11-05T21:08:37+00:00 0.5 https://www.ucb-usa.com/HealthSafetyWellbeing 2025-04-16T10:05:58+01:00 0.5 https://www.ucb-usa.com/Patients/Population-Health-At-Ucb 2025-12-16T16:46:29+00:00 0.5 https://www.ucb-usa.com/Innovation/Products/Fintepla 2025-10-16T12:59:36+01:00 0.5 https://www.ucb-usa.com/Patients/moments-that-matter 2025-12-16T16:53:24+00:00 0.5 https://www.ucb-usa.com/UCB-in-the-U-S/U-S-Leadership-Team/Brandon-Drew 2024-07-22T15:03:27+01:00 0.5 https://www.ucb-usa.com/UCB-in-the-U-S/U-S-Leadership-Team/Brad-Chapman 2024-07-27T00:58:12+01:00 0.5 https://www.ucb-usa.com/Innovation/Research-Development 2025-10-22T21:46:07+01:00 0.5 https://www.ucb-usa.com/Sustainability/Affordability/Fintepla-Pricing-Info 2026-03-16T12:44:20+00:00 0.5 https://www.ucb-usa.com/Sustainability/access-to-medicines 2026-03-10T13:53:54+00:00 0.5 https://www.ucb-usa.com/Healthcare-Professionals/Immunology-Wellness-Connect 2024-04-02T13:09:05+01:00 0.5 https://www.ucb-usa.com/Healthcare-Professionals/Immunology-Wellness-Connect/Wellness4U 2025-10-17T13:14:53+01:00 0.5 https://www.ucb-usa.com/Healthcare-Professionals/Immunology-Wellness-Connect/Wellness4U/Programs 2025-10-24T18:19:39+01:00 0.5 https://www.ucb-usa.com/Healthcare-Professionals/Immunology-Wellness-Connect/Population-Health 2025-10-21T16:06:15+01:00 0.5 https://www.ucb-usa.com/Healthcare-Professionals/Immunology-Wellness-Connect/Population-Health/Dermatology 2025-10-06T20:34:02+01:00 0.5 https://www.ucb-usa.com/Immunology-Wellness-Connect/Population-Health/Rheumatology 2025-10-06T20:25:09+01:00 0.5 https://www.ucb-usa.com/Healthcare-Professionals/Immunology-Wellness-Connect/Population-Health/Health-Systems 2025-10-06T20:28:45+01:00 0.5 https://www.ucb-usa.com/Healthcare-Professionals/Immunology-Wellness-Connect/Wellness4U/Speakers 2025-10-21T09:40:45+01:00 0.5 https://www.ucb-usa.com/Healthcare-Professionals/Immunology-Wellness-Connect/Wellness4U/Speakers/Leonard-H-Calabrese 2025-10-21T10:36:14+01:00 0.5 https://www.ucb-usa.com/Healthcare-Professionals/Immunology-Wellness-Connect/Wellness4U/Speakers/William-Cragun 2024-04-02T13:53:38+01:00 0.5 https://www.ucb-usa.com/Healthcare-Professionals/Immunology-Wellness-Connect/Wellness4U/Speakers/Steve-Daveluy 2024-04-02T13:54:20+01:00 0.5 https://www.ucb-usa.com/Healthcare-Professionals/Immunology-Wellness-Connect/Wellness4U/Speakers/Soha-Dolatabadi 2024-04-02T13:54:33+01:00 0.5 https://www.ucb-usa.com/Healthcare-Professionals/Immunology-Wellness-Connect/Wellness4U/Speakers/Amy-McMichael 2025-10-21T10:42:59+01:00 0.5 https://www.ucb-usa.com/Healthcare-Professionals/Immunology-Wellness-Connect/Wellness4U/Speakers/George-Munoz 2025-10-21T10:44:24+01:00 0.5 https://www.ucb-usa.com/Healthcare-Professionals/Immunology-Wellness-Connect/Wellness4U/Speakers/Jenny-Murase 2025-10-21T10:45:37+01:00 0.5 https://www.ucb-usa.com/Healthcare-Professionals/Immunology-Wellness-Connect/Wellness4U/Speakers/Raja-Sivamani 2025-10-21T10:45:56+01:00 0.5 https://www.ucb-usa.com/Healthcare-Professionals/Immunology-Wellness-Connect/Wellness4U/Speakers/Beth-Sweney 2025-10-21T10:54:16+01:00 0.5 https://www.ucb-usa.com/Healthcare-Professionals/Immunology-Wellness-Connect/Wellness4U/Programs/Chronic-Inflammatory-Diseases-Influences-of-the-Microbiome-and-Considerations-for-Holistic-Patient-Care 2025-10-21T10:00:01+01:00 0.5 https://www.ucb-usa.com/Healthcare-Professionals/Immunology-Wellness-Connect/Wellness4U/Programs/More-Than-Skin-Deep-A-Joint-Approach-to-Managing-Psoriatic-Disease 2025-10-21T09:58:55+01:00 0.5 https://www.ucb-usa.com/Healthcare-Professionals/Immunology-Wellness-Connect/Wellness4U/Programs/Under-My-Skin-A-Holistic-Approach-to-Support-the-Health-and-Wellness-of-Patients-with-Psoriasis 2025-10-21T09:58:27+01:00 0.5 https://www.ucb-usa.com/healthoftheplanet 2025-04-16T09:50:59+01:00 0.5 https://www.ucb-usa.com/Immunology-Wellness-Connect/Wellness4U/Professional-and-Advocacy-Programs 2025-10-21T09:45:47+01:00 0.5 https://www.ucb-usa.com/Healthcare-Professionals/Immunology-Wellness-Connect/Wellness4U/HCP-Resources 2025-10-21T09:46:49+01:00 0.5 https://www.ucb-usa.com/Healthcare-Professionals/Immunology-Wellness-Connect/Wellness4U/Programs/Uncovering-Patients-in-Plain-Sight-Recognizing-and-Diagnosing-Patients-Living-With-nr-axSpA 2025-10-21T09:57:28+01:00 0.5 https://www.ucb-usa.com/Healthcare-Professionals/Immunology-Wellness-Connect/Wellness4U/Programs/Sharing-the-Stage-Empowering-Patients-Through-Shared-Decision-Making 2025-10-21T09:57:49+01:00 0.5 https://www.ucb-usa.com/Sustainability/Affordability/Bimzelx-Pricing-Info 2026-01-07T01:35:26+00:00 0.5 https://www.ucb-usa.com/Innovation/Products/Bimzelx 2025-07-02T20:54:43+01:00 0.5 https://www.ucb-usa.com/Sustainability/Affordability/RYSTIGGO-Pricing-Info 2026-01-07T19:07:42+00:00 0.5 https://www.ucb-usa.com/Innovation/Products/Rystiggo 2025-07-02T21:33:39+01:00 0.5 https://www.ucb-usa.com/UCB-in-the-U-S/U-S-Leadership-Team/Jennifer-Johnson 2023-06-15T21:54:24+01:00 0.5 https://www.ucb-usa.com/Innovation/Products/ZILBRYSQ 2026-03-04T20:13:10+00:00 0.5 https://www.ucb-usa.com/Sustainability/Affordability/ZILBRYSQ-Pricing-Info 2026-01-07T18:59:09+00:00 0.5 https://www.ucb-usa.com/innovation/care-reproductive-health-query-set 2023-09-13T22:21:37+01:00 0.5 https://www.ucb-usa.com/Healthcare-Professionals/Immunology-Wellness-Connect/Wellness4U/Programs/Addressing-the-Unique-Considerations-of-Women-of-Reproductive-Potential-With-Immune-Mediated-Inflammatory-Diseases 2025-10-21T10:00:27+01:00 0.5 https://www.ucb-usa.com/Healthcare-Professionals/Immunology-Wellness-Connect/Wellness4U/Join-a-Program 2025-10-21T15:46:50+01:00 0.5 https://www.ucb-usa.com/Healthcare-Professionals/Immunology-Wellness-Connect/Wellness4U/Speakers/Elizabeth-A-Kiracofe 2025-10-21T10:37:02+01:00 0.5 https://www.ucb-usa.com/Healthcare-Professionals/Immunology-Wellness-Connect/Wellness4U/Feedback-Survey 2025-10-21T09:48:16+01:00 0.5 https://www.ucb-usa.com/404 2023-09-21T07:27:35+01:00 0.5 https://www.ucb-usa.com/403 2023-09-21T07:26:14+01:00 0.5 https://www.ucb-usa.com/Disease-Areas/Rheumatology 2025-04-16T09:38:13+01:00 0.5 https://www.ucb-usa.com/UCB-in-the-U-S/U-S-Leadership-Team/Jaime-Davis 2024-07-22T15:07:43+01:00 0.5 https://www.ucb-usa.com/UCB-in-the-U-S/U-S-Leadership-Team/Michele-Ehler 2025-02-13T20:22:48+00:00 0.5 https://www.ucb-usa.com/UCB-in-the-U-S/U-S-Leadership-Team/Tonja-Pitts 2024-07-27T00:06:22+01:00 0.5 https://www.ucb-usa.com/Healthcare-Professionals/Immunology-Wellness-Connect/Wellness4U/Speakers/Angela-Crowley 2025-05-06T09:20:27+01:00 0.5 https://www.ucb-usa.com/Healthcare-Professionals/Immunology-Wellness-Connect/Wellness4U/Speakers/Timothy-F-Lazarek 2024-08-02T21:58:57+01:00 0.5 https://www.ucb-usa.com/Healthcare-Professionals/Immunology-Wellness-Connect/Wellness4U/Speakers/Julia-Wu 2025-10-21T15:45:42+01:00 0.5 https://www.ucb-usa.com/Healthcare-Professionals/Immunology-Wellness-Connect/Wellness4U/Programs/JOINTogether-holistic-care-approaches-to-support-the-management-of-disease-activity-in-patients-with-Psoriatic-arthritis-and-axial-spondyloarthritis 2025-10-21T15:16:18+01:00 0.5 https://www.ucb-usa.com/Healthcare-Professionals/Immunology-Wellness-Connect/Wellness4U/Programs/impact-of-immune-mediated-inflammatory-diseases-imids-considerations-for-patients-with-systemic-manifestations 2025-10-21T15:18:21+01:00 0.5 https://www.ucb-usa.com/UCB-in-the-U-S/U-S-Leadership-Team/Taco-van-Tiel 2024-08-07T03:24:32+01:00 0.5 https://www.ucb-usa.com/Disease-Areas/ucb-in-ears 2025-12-16T16:46:59+00:00 0.5 https://www.ucb-usa.com/Disease-Areas/Disease-Areas 2025-12-16T16:40:21+00:00 0.5 https://www.ucb-usa.com/Healthcare-Professionals/Immunology-Wellness-Connect/Wellness4U/Speakers/Iltefat-Hamzavi 2025-10-21T15:18:45+01:00 0.5 https://www.ucb-usa.com/Healthcare-Professionals/Immunology-Wellness-Connect/Wellness4U/Speakers/Hadar-Lev-Tov 2025-10-21T15:45:25+01:00 0.5 https://www.ucb-usa.com/UCB-in-the-U-S/U-S-Leadership-Team/James-Hlavenka 2025-05-30T13:50:57+01:00 0.5 https://www.ucb-usa.com/Innovation/Products/KYGEVVI 2025-11-08T02:35:04+00:00 0.5 https://www.ucb-usa.com/Healthcare-Professionals/Immunology-Wellness-Connect/Wellness4U/Speakers/Jawad-Bilal 2025-10-21T10:35:19+01:00 0.5 https://www.ucb-usa.com/Sustainability/Affordability/KYGEVVI-Pricing-info 2026-03-16T13:03:01+00:00 0.5 https://www.ucb-usa.com/stories-media/UCB-U-S-News/detail/article/The-Lancet-Publishes-Two-Phase-3-Studies-Detailing-Bimekizumab-Data-in-Moderate-to-Severe-Plaque-Psoriasis 2025-05-19T09:31:24+01:00 0.5 https://www.ucb-usa.com/stories-media/UCB-U-S-News/detail/article/UCB-and-Microsoft-Expand-Collaboration-to-Accelerate-Drug-Discovery-and-Development 2025-05-19T09:31:35+01:00 0.5 https://www.ucb-usa.com/stories-media/UCB-U-S-News/detail/article/UCB-Showcases-Approach-to-Creating-Patient-Value-in-Immuno-Dermatology 2025-05-19T09:34:20+01:00 0.5 https://www.ucb-usa.com/stories-media/UCB-U-S-News/detail/article/UCB-to-Present-12-Abstracts-on-Bimekizumab-at-AAD-VMX-2021 2025-05-19T09:35:14+01:00 0.5 https://www.ucb-usa.com/stories-media/UCB-U-S-News/detail/article/The-New-England-Journal-of-Medicine-Publishes-Results-from-Two-Bimekizumab-Phase-3-Studies-in-Moderate-to-Severe-Plaque-Psoriasis 2025-05-19T09:35:23+01:00 0.5 https://www.ucb-usa.com/stories-media/UCB-U-S-News/detail/article/ucb-announces-pdufa-date-bimekizumab 2025-05-19T09:35:05+01:00 0.5 https://www.ucb-usa.com/stories-media/UCB-U-S-News/detail/article/anita-moser-and-erica-puntel-recognized-2021-hba-rising 2025-05-19T09:31:49+01:00 0.5 https://www.ucb-usa.com/stories-media/UCB-U-S-News/detail/article/ucb-statement-non-radiographic-axial-spondyloarthritis 2025-05-19T09:32:00+01:00 0.5 https://www.ucb-usa.com/stories-media/UCB-U-S-News/detail/article/all-us-vs-psoriasis 2025-05-19T10:05:31+01:00 0.5 https://www.ucb-usa.com/stories-media/UCB-U-S-News/detail/article/new-two-year-data-showed-bimekizumab-maintained-high 2025-05-19T09:32:13+01:00 0.5 https://www.ucb-usa.com/stories-media/UCB-U-S-News/detail/article/ucb-announces-briviact-brivaracetam-cv-now-fda-approved-pediatric 2025-05-19T09:34:53+01:00 0.5 https://www.ucb-usa.com/stories-media/UCB-U-S-News/detail/article/new-bimekizumab-two-year-data-moderate-severe-plaque-psoriasis-presented-at-EADV-Congress 2025-05-19T09:32:31+01:00 0.5 https://www.ucb-usa.com/stories-media/UCB-U-S-News/detail/article/bimzelx-approved-by-the-us-fda-for-the-treatment-of-adults-with-moderate-to-severe-plaque-psoriasis 2025-05-19T10:25:16+01:00 0.5 https://www.ucb-usa.com/stories-media/UCB-U-S-News/detail/article/update-us-fda-review-biologics-license-application-bla 2025-05-19T09:32:38+01:00 0.5 https://www.ucb-usa.com/stories-media/UCB-U-S-News/detail/article/ucb-presents-number-needed-treat-analysis-bimekizumab-in-Moderate-to-Severe-Plaque-Psoriasis-at-AMCP-Nexus 2025-05-19T09:33:02+01:00 0.5 https://www.ucb-usa.com/stories-media/UCB-U-S-News/detail/article/ucb-showcases-key-rheumatology-data-acr-convergence-2021 2025-05-19T09:32:49+01:00 0.5 https://www.ucb-usa.com/stories-media/UCB-U-S-News/detail/article/positive-top-line-results-bimekizumab-phase-3-psoriatic-arthritis-study-demonstrated-significant-improvements-in-joint-and-skin-symptoms 2025-05-19T09:33:11+01:00 0.5 https://www.ucb-usa.com/stories-media/UCB-U-S-News/detail/article/ucb-announces-positive-phase-3-results-rozanolixizumab 2025-05-19T09:33:59+01:00 0.5 https://www.ucb-usa.com/stories-media/UCB-U-S-News/detail/article/positive-top-line-results-bimekizumab-phase-3-ankylosing 2025-05-19T09:34:09+01:00 0.5 https://www.ucb-usa.com/stories-media/UCB-U-S-News/detail/article/positive-top-line-results-bimekizumab-phase-3-non-radiographic-axial-spondyloarthritis-study 2025-05-19T09:35:32+01:00 0.5 https://www.ucb-usa.com/stories-media/UCB-U-S-News/detail/article/ucb-acquire-zogenix 2025-05-19T09:33:20+01:00 0.5 https://www.ucb-usa.com/stories-media/UCB-U-S-News/detail/article/positive-top-line-results-bimekizumab-second-phase-3-psoriatic-arthritis-study 2025-05-19T09:34:32+01:00 0.5 https://www.ucb-usa.com/stories-media/UCB-U-S-News/detail/article/ucb-announces-positive-data-in-myasthenia-gravis-with-zilucoplan-phase-3-study-results 2025-05-19T09:34:43+01:00 0.5 https://www.ucb-usa.com/stories-media/UCB-U-S-News/detail/article/recognizing-myasthenia-gravis-month-importance-addressing 2025-05-30T19:48:21+01:00 0.5 https://www.ucb-usa.com/stories-media/UCB-U-S-News/detail/article/partnering-greater-impact-microsoft-rd 2025-05-19T09:39:26+01:00 0.5 https://www.ucb-usa.com/stories-media/UCB-U-S-News/detail/article/ucb-completes-acquisition-of-zogenix-inc 2025-05-19T09:39:04+01:00 0.5 https://www.ucb-usa.com/stories-media/UCB-U-S-News/detail/article/fintepla-fenfluramine-oral-solution-now-fda-approved-for-treatment-of-seizures-associated-with-lennox-gastaut-syndrome-lgs 2025-05-19T09:39:35+01:00 0.5 https://www.ucb-usa.com/stories-media/UCB-U-S-News/detail/article/new-long-term-complete-skin-clearance-data-for-bimekizumab-in-moderate-to-severe-plaque-psoriasis-presented-at-the-2022-aad-annual-meeting 2025-05-19T09:35:50+01:00 0.5 https://www.ucb-usa.com/stories-media/UCB-U-S-News/detail/article/ucb-presents-efficacy-and-safety-results-for-zilucoplan-and-rozanolixizumad-in-generalized-myasthenia-gravis 2025-05-19T09:40:29+01:00 0.5 https://www.ucb-usa.com/stories-media/UCB-U-S-News/detail/article/recognizing-our-rising-star-and-luminary-kerry-black-and 2025-05-28T18:00:56+01:00 0.5 https://www.ucb-usa.com/stories-media/UCB-U-S-News/detail/article/recognizing-less-common-equally-burdensome-forms 2025-05-19T10:14:12+01:00 0.5 https://www.ucb-usa.com/stories-media/UCB-U-S-News/detail/article/first-presentations-of-phase-3-data-bimekizumab-across-full-spectrum-of-axial-spondyloartritis-to-be-shared-at-eular-2022 2025-05-19T09:40:16+01:00 0.5 https://www.ucb-usa.com/stories-media/UCB-U-S-News/detail/article/ucb-announces-first-detailed-data-from-two-phase-3-bimekizumab-studies-in-psoriatic-arthritis-to-be-presented-at-eular-2022 2025-05-19T09:40:07+01:00 0.5 https://www.ucb-usa.com/stories-media/UCB-U-S-News/detail/article/my-commitment-to-the-newly-diagnosed-and-all-people-living-with-myasthenia-gravis 2025-05-19T10:06:56+01:00 0.5 https://www.ucb-usa.com/stories-media/UCB-U-S-News/detail/article/life-mg-what-i-wish-everyone-who-diagnosed 2025-05-19T10:05:05+01:00 0.5 https://www.ucb-usa.com/stories-media/UCB-U-S-News/detail/article/ucb-hosts-hrh-princess-astrid-and-belgian-economic 2025-05-19T10:04:50+01:00 0.5 https://www.ucb-usa.com/stories-media/UCB-U-S-News/detail/article/ucb-builds-partnerships-rare-epilepsy-syndrome-patient 2025-05-19T10:04:35+01:00 0.5 https://www.ucb-usa.com/stories-media/UCB-U-S-News/detail/article/how-winners-ucb-family-epilepsy-scholarship-prepare-go 2025-05-19T10:06:29+01:00 0.5 https://www.ucb-usa.com/stories-media/UCB-U-S-News/detail/article/ucb-partners-in-health-economics-and-outcomes-research-to-evolve-solutions-for-seizure-clusters 2025-05-19T10:06:42+01:00 0.5 https://www.ucb-usa.com/stories-media/UCB-U-S-News/detail/article/ucb-presents-latest-data-from-generalized-myasthenia-gravis-portfolio-at-aanem-meeting 2025-05-19T10:07:10+01:00 0.5 https://www.ucb-usa.com/stories-media/UCB-U-S-News/detail/article/ucb-achieves-two-awards-recognizing-our-sustainability-efforts-for-the-atlanta-warehouse-expansion 2025-05-19T10:07:25+01:00 0.5 https://www.ucb-usa.com/stories-media/UCB-U-S-News/detail/article/ucb-u-s-headquarters-in-atlanta-awarded-prestigious-leed-gold-and-well-platinum-certifications 2025-05-19T10:08:46+01:00 0.5 https://www.ucb-usa.com/stories-media/UCB-U-S-News/detail/article/ucb-announces-us-fda-acceptance-of-new-drug-application-and-ema-maa-validation-for-zilucoplan-for-the-treatment-of-generalized-myasthenia-gravis-in-adult-patients 2025-05-19T10:09:40+01:00 0.5 https://www.ucb-usa.com/stories-media/UCB-U-S-News/detail/article/ucb-submits-response-to-fda-complete-response-letter-for-bimekizumab 2025-05-19T10:10:14+01:00 0.5 https://www.ucb-usa.com/stories-media/UCB-U-S-News/detail/article/the-lancet-publishes-results-from-two-bimekizumab-phase-3-studies-in-psoriatic-arthritis 2025-05-19T10:10:23+01:00 0.5 https://www.ucb-usa.com/stories-media/UCB-U-S-News/detail/article/employee-spotlight-leah-vanderveen-and-her-time-court 2025-05-19T10:10:59+01:00 0.5 https://www.ucb-usa.com/stories-media/UCB-U-S-News/detail/article/ucb-announces-fda-acceptance-of-bla-resubmission-for-bimekizumab 2025-05-19T10:10:03+01:00 0.5 https://www.ucb-usa.com/stories-media/UCB-U-S-News/detail/article/ucb-announces-rozanolixizumab-bla-for-the-treatment-of-generalized-myasthenia-gravis-filed-with-us-fda-and-designated-for-priority-review 2025-05-19T10:11:08+01:00 0.5 https://www.ucb-usa.com/stories-media/UCB-U-S-News/detail/article/annals-of-the-rheumatic-diseases-publishes-results-from-two-bimekizumab-phase-3-studies-in-axial-spondyloarthritis 2025-05-19T10:11:28+01:00 0.5 https://www.ucb-usa.com/stories-media/UCB-U-S-News/detail/article/employee-spotlight-ian-crassweller-leading-and-evolving 2025-05-19T10:11:37+01:00 0.5 https://www.ucb-usa.com/stories-media/UCB-U-S-News/detail/article/patient-first-patient-focused-our-purpose-and-promise-on-rare-disease-day-2023 2025-05-19T10:12:59+01:00 0.5 https://www.ucb-usa.com/stories-media/UCB-U-S-News/detail/article/building-community-trust-epilepsy-rare-syndromes 2025-10-22T18:47:38+01:00 0.5 https://www.ucb-usa.com/stories-media/UCB-U-S-News/detail/article/you-speak-we-listen-how-community-voices-drive-our-work 2025-05-19T10:14:39+01:00 0.5 https://www.ucb-usa.com/stories-media/UCB-U-S-News/detail/article/exploring-future-dermatology-aad-2023 2025-05-19T10:12:35+01:00 0.5 https://www.ucb-usa.com/stories-media/UCB-U-S-News/detail/article/ucbs-commitment-understanding-sudden-unexpected-death 2025-05-19T10:13:21+01:00 0.5 https://www.ucb-usa.com/stories-media/UCB-U-S-News/detail/article/recognizing-ucbs-rising-stars-brittany-blair-and-lauren 2025-05-19T10:13:29+01:00 0.5 https://www.ucb-usa.com/stories-media/UCB-U-S-News/detail/article/ucb-announces-fintepla-fenfluramine-oral-solution-is-now-descheduled-and-is-no-longer-listed-as-a-controlled-substance 2025-05-19T10:13:41+01:00 0.5 https://www.ucb-usa.com/stories-media/UCB-U-S-News/detail/article/how-shared-decision-making-creates-better-patient-provider-collaboration-in-dermatology 2025-05-19T10:27:02+01:00 0.5 https://www.ucb-usa.com/stories-media/UCB-U-S-News/detail/article/ucb-showcases-strength-and-depth-of-neurology-portfolio-at-75th-american-academy-of-neurology-aan-annual-meeting 2025-05-19T10:13:48+01:00 0.5 https://www.ucb-usa.com/stories-media/UCB-U-S-News/detail/article/earth-day-2023-our-commitment-sustainability-workplace 2025-05-19T10:13:55+01:00 0.5 https://www.ucb-usa.com/stories-media/UCB-U-S-News/detail/article/voices-on-value-breaking-down-the-value-chain-policies-impacting-patients 2025-05-19T10:14:03+01:00 0.5 https://www.ucb-usa.com/stories-media/UCB-U-S-News/detail/article/myasthenia-gravis-awareness-month-time-understand-more-about-the-lived-experiences-of-the-community 2025-05-19T10:14:21+01:00 0.5 https://www.ucb-usa.com/stories-media/UCB-U-S-News/detail/article/prioritizing-mental-health-caregiver-child-dravet 2025-05-19T10:14:30+01:00 0.5 https://www.ucb-usa.com/stories-media/UCB-U-S-News/detail/article/recognizing-ethical-leadership-ucb 2025-05-19T10:15:31+01:00 0.5 https://www.ucb-usa.com/stories-media/UCB-U-S-News/detail/article/how-ucb-supporting-mental-health-patients-and-caregivers 2025-05-19T10:29:53+01:00 0.5 https://www.ucb-usa.com/stories-media/UCB-U-S-News/detail/article/fulfilling-our-ambition-deliver-fda-approved-treatment 2025-05-19T10:17:03+01:00 0.5 https://www.ucb-usa.com/stories-media/UCB-U-S-News/detail/article/ucb-announces-us-fda-approval-of-rystiggo-rozanolixizumab-noli-for-the-treatment-of-adults-with-generalized-myasthenia-gravis 2025-05-19T10:15:50+01:00 0.5 https://www.ucb-usa.com/stories-media/UCB-U-S-News/detail/article/ucb-announces-us-availability-of-rystiggo-rozanolixizumab-noli-for-the-treatment-of-generalized-myasthenia-gravis-gmg-in-adult-patients-who-are-anti-acetylcholine-receptor-achr-or-anti-muscle-specific-tyrosine 2025-05-19T10:15:59+01:00 0.5 https://www.ucb-usa.com/stories-media/UCB-U-S-News/detail/article/evolving-expectations-dermatological-conditions 2025-05-19T10:16:34+01:00 0.5 https://www.ucb-usa.com/stories-media/UCB-U-S-News/detail/article/employee-spotlight-david-hornbakers-heart-helping 2025-05-19T10:16:45+01:00 0.5 https://www.ucb-usa.com/stories-media/UCB-U-S-News/detail/article/announcing-2023-ucb-family-epilepsy-scholarship-winners 2025-05-19T10:17:11+01:00 0.5 https://www.ucb-usa.com/stories-media/UCB-U-S-News/detail/article/ucb-pharmd-second-year-fellows-share-reflections-and 2025-05-28T16:55:14+01:00 0.5 https://www.ucb-usa.com/stories-media/UCB-U-S-News/detail/article/ucb-presents-late-breaking-posters-at-child-neurology-society-meeting 2025-05-19T10:17:27+01:00 0.5 https://www.ucb-usa.com/stories-media/UCB-U-S-News/detail/article/phase-3-data-analysis-presented-at-eadv-2023-showed-bimekizumab-achieved-high-thresholds-of-clinical-response-in-hidradenitis-suppurativa 2025-05-19T10:17:46+01:00 0.5 https://www.ucb-usa.com/stories-media/UCB-U-S-News/detail/article/ucb-announces-us-fda-approval-of-zilbrysq-zilucoplan-for-the-treatment-of-adults-with-generalized-myasthenia-gravis 2025-05-19T10:23:02+01:00 0.5 https://www.ucb-usa.com/stories-media/UCB-U-S-News/detail/article/steadfast-towards-our-ambition-20-create-a-ucb-rare-disease-portfolio 2025-05-19T10:24:33+01:00 0.5 https://www.ucb-usa.com/stories-media/UCB-U-S-News/detail/article/evolving-expectations-for-dermatological-conditions 2025-05-19T10:23:53+01:00 0.5 https://www.ucb-usa.com/stories-media/UCB-U-S-News/detail/article/nayzilam-midazolam-results-published-in-epilepsy-behavior-examining-the-impact-of-dose-on-return-to-full-baseline-function-rtfbf-for-people-with-seizure-clusters 2025-05-19T10:24:41+01:00 0.5 https://www.ucb-usa.com/stories-media/UCB-U-S-News/detail/article/ucb-presents-latest-data-from-generalized-myasthenia-gravis-portfolio-at-2023-american-association-of-neuromuscular-electrodiagnostic-medicine-annual-meeting 2025-05-19T10:24:49+01:00 0.5 https://www.ucb-usa.com/stories-media/UCB-U-S-News/detail/article/partnering-caregivers-advance-ecosystem-care-rare 2025-05-19T10:24:56+01:00 0.5 https://www.ucb-usa.com/stories-media/UCB-U-S-News/detail/article/advancing-rheumatic-disease-treatment 2025-05-19T10:25:04+01:00 0.5 https://www.ucb-usa.com/stories-media/UCB-U-S-News/detail/article/ucb-presents-new-five-year-data-bimzelxr-bimekizumab-bkzx-in-ankylosing-spondylitis-at-acr-convergence-2023 2025-05-19T10:25:25+01:00 0.5 https://www.ucb-usa.com/stories-media/UCB-U-S-News/detail/article/ucb-announces-us-availability-of-bimzelx-for-the-treatment-of-adults-with-moderate-to-severe-plaque-psoriasis 2025-05-19T10:25:42+01:00 0.5 https://www.ucb-usa.com/stories-media/UCB-U-S-News/detail/article/employee-spotlight-stephen-mayclins-impact-working-cures 2025-05-19T10:25:52+01:00 0.5 https://www.ucb-usa.com/stories-media/UCB-U-S-News/detail/article/ucb-presents-new-data-advancing-patient-focused-scientific-leadership-at-american-epilepsy-society-annual-meeting 2025-05-19T10:26:01+01:00 0.5 https://www.ucb-usa.com/stories-media/UCB-U-S-News/detail/article/media-statement-on-levetiracetam-keppra-and-keppra-xr-and-dress 2025-05-19T10:26:12+01:00 0.5 https://www.ucb-usa.com/stories-media/UCB-U-S-News/detail/article/ucb-presents-new-data-about-real-world-experience-of-fintepla-fenfluramine-and-rare-epilepsy-syndromes-at-2023-american-epilepsy-society-annual-meeting 2025-05-19T10:26:23+01:00 0.5 https://www.ucb-usa.com/stories-media/UCB-U-S-News/detail/article/ZILBRYSQ-zilucoplan-now-commercially-available-in-the-us-for-the-treatment-of-generalized-myasthenia-gravis-gmg-in-adult-patients-who-are-anti-acetylcholine-receptor-achr-antibody-positive 2025-05-19T10:26:31+01:00 0.5 https://www.ucb-usa.com/stories-media/UCB-U-S-News/detail/article/our-wish-2024-renewed-hope-people-living-chronic 2025-05-19T10:26:39+01:00 0.5 https://www.ucb-usa.com/stories-media/UCB-U-S-News/detail/article/harmony-health-partnering-enhanced-seizure-management-and 2025-05-19T10:26:49+01:00 0.5 https://www.ucb-usa.com/stories-media/UCB-U-S-News/detail/article/rare-disease-day-2024-moment-now-be-patient-first-deliver 2025-05-19T10:27:19+01:00 0.5 https://www.ucb-usa.com/stories-media/UCB-U-S-News/detail/article/ucb-on-growth-path-for-a-decade-plus 2025-05-19T10:27:11+01:00 0.5 https://www.ucb-usa.com/stories-media/UCB-U-S-News/detail/article/putting-people-first-create-more-sustainable-healthcare 2025-05-19T10:27:31+01:00 0.5 https://www.ucb-usa.com/stories-media/UCB-U-S-News/detail/article/innovating-and-collaborating-immuno-dermatology-dialogue 2025-05-19T14:13:43+01:00 0.5 https://www.ucb-usa.com/stories-media/UCB-U-S-News/detail/article/bimzelx-48-week-phase-3-analyses-in-moderate-to-severe-hidradenitis-suppurativa-showed-sustained-improvements-in-skin-pain-and-draining-tunnel-count 2025-05-19T10:27:38+01:00 0.5 https://www.ucb-usa.com/stories-media/UCB-U-S-News/detail/article/first-presentation-year-4-bimzelxr-bimekizumab-bkzx-data-showed-long-term-maintenance-of-complete-skin-clearance-in-moderate-to-severe-plaque-psoriasis 2025-05-19T10:27:49+01:00 0.5 https://www.ucb-usa.com/stories-media/UCB-U-S-News/detail/article/patty-fritz-and-bianca-anderson-recognized-healthcare 2025-05-19T10:28:00+01:00 0.5 https://www.ucb-usa.com/stories-media/UCB-U-S-News/detail/article/our-leadership-and-legacy-epilepsy-and-rare-syndromes 2025-05-19T10:28:32+01:00 0.5 https://www.ucb-usa.com/stories-media/UCB-U-S-News/detail/article/ucb-presents-new-data-highlighting-developments-across-expansive-neurology-portfolio-at-76th-american-academy-of-neurology-aan-annual-meeting 2025-05-19T10:28:40+01:00 0.5 https://www.ucb-usa.com/stories-media/UCB-U-S-News/detail/article/moms-really-can-do-it-all-meet-tracy-mom-caregiver 2025-05-19T11:07:25+01:00 0.5 https://www.ucb-usa.com/stories-media/UCB-U-S-News/detail/article/ucb-announces-publication-in-the-lancet-of-phase-3-bimzelx-bimekizumab-bkzx-trials-in-moderate-to-severe-hidradenitis-suppurativa 2025-05-19T10:28:59+01:00 0.5 https://www.ucb-usa.com/stories-media/UCB-U-S-News/detail/article/go-behind-mystery-myasthenia-gravis-myasthenia-gravis 2025-05-19T10:29:17+01:00 0.5 https://www.ucb-usa.com/stories-media/UCB-U-S-News/detail/article/nicole-watson-mom-caregiver-and-best-friend-shares-how 2025-05-19T10:30:48+01:00 0.5 https://www.ucb-usa.com/stories-media/UCB-U-S-News/detail/article/ucb-to-share-first-presentations-of-bimzelxr-bimekizumab-bkzx-two-year-data-in-axial-spondyloarthritis-and-psoriatic-arthritis-at-EULAR-2024 2025-05-19T10:30:29+01:00 0.5 https://www.ucb-usa.com/stories-media/UCB-U-S-News/detail/article/ucb-eular-2024-advancing-science-rheumatic-conditions 2025-05-19T10:30:56+01:00 0.5 https://www.ucb-usa.com/stories-media/UCB-U-S-News/detail/article/ucb-launches-dravet-syndrome-sound-profound-moments 2025-05-19T10:31:12+01:00 0.5 https://www.ucb-usa.com/stories-media/UCB-U-S-News/detail/article/FINTEPLA-fenfluramine-results-examining-its-impact-in-managing-generalized-tonic-clonic-seizures-in-developmental-and-epileptic-encephalopathies-published-in-epilepsia 2025-05-19T10:31:04+01:00 0.5 https://www.ucb-usa.com/stories-media/UCB-U-S-News/detail/article/helen-tarleton-recognized-working-cures-employee-champion 2025-05-19T10:31:21+01:00 0.5 https://www.ucb-usa.com/stories-media/UCB-U-S-News/detail/article/ucb-partners-emmy-award-winner-ben-decter-and-tony-award 2025-05-19T10:40:08+01:00 0.5 https://www.ucb-usa.com/stories-media/UCB-U-S-News/detail/article/ucb-elevates-hidradenitis-suppurativa-awareness-at-inaugural-patient-and-hcp-summit-with-special-appearance-by-dr-sandra-lee-aka-dr-pimple-popper 2025-05-19T10:40:20+01:00 0.5 https://www.ucb-usa.com/stories-media/UCB-U-S-News/detail/article/homework-holidays-how-families-living-epilepsy-can 2025-05-19T10:40:29+01:00 0.5 https://www.ucb-usa.com/stories-media/UCB-U-S-News/detail/article/legacy-continues-celebrating-two-decades-ucb-family 2025-05-19T10:40:37+01:00 0.5 https://www.ucb-usa.com/stories-media/UCB-U-S-News/detail/article/tk2d-awareness-day-complexity-rare-genetic-mitochondrial 2025-05-19T10:40:47+01:00 0.5 https://www.ucb-usa.com/stories-media/UCB-U-S-News/detail/article/redefining-immunology-care-our-pledge-to-patients-and-the-healthcare-community 2025-05-19T10:40:55+01:00 0.5 https://www.ucb-usa.com/stories-media/UCB-U-S-News/detail/article/ucb-announces-us-fda-approvals-for-bimzelxr-bimekizumab-bkzx-for-the-treatment-of-psoriatic-arthritis-non-radiographic-axial-spondyloarthritis-and-ankylosing-spondylitis 2025-05-19T10:41:06+01:00 0.5 https://www.ucb-usa.com/stories-media/UCB-U-S-News/detail/article/ucb-presents-new-4-year-data-for-bimzelxr-bimekizumab-bkzx-in-moderate-to-severe-plaque-psoriasis-at-eadv-2024 2025-05-19T10:41:18+01:00 0.5 https://www.ucb-usa.com/stories-media/UCB-U-S-News/detail/article/ucb-announces-a-head-to-head-study-evaluating-bimzelx-bimekizumab-versus-skyrizi-risankizumab-in-active-psoriatic-arthritis 2025-05-19T11:06:35+01:00 0.5 https://www.ucb-usa.com/stories-media/UCB-U-S-News/detail/article/ucb-showcases-new-data-for-gmg-management-at-2024-american-association-of-neuromuscular-electrodiagnostic-medicine-aanem-annual-meeting-and-myasthenia-gravis-foundation-of-america-mgfa-scientific-session 2025-05-19T11:06:46+01:00 0.5 https://www.ucb-usa.com/stories-media/UCB-U-S-News/detail/article/ucb-receives-us-fda-approval-for-320-mg-single-injection-device-presentations-of-bimzelx-bimekizumab-bkzx 2025-05-19T11:06:56+01:00 0.5 https://www.ucb-usa.com/stories-media/UCB-U-S-News/detail/article/ucb-announces-us-launch-of-ucb-myasthenia-gravis-scholarship 2025-05-19T11:07:06+01:00 0.5 https://www.ucb-usa.com/stories-media/UCB-U-S-News/detail/article/powering-dreams-people-impacted-myasthenia-gravis-mg 2025-05-19T11:07:15+01:00 0.5 https://www.ucb-usa.com/stories-media/UCB-U-S-News/detail/article/bright-future-prioritizing-early-diagnosis-maintenance 2025-05-19T11:08:28+01:00 0.5 https://www.ucb-usa.com/stories-media/UCB-U-S-News/detail/article/new-bimzelxr-bimekizumab-bkzx-data-at-acr-convergence-2024-highlights-ucbs-efforts-to-deliver-differentiated-care-for-patients-with-psoriatic-arthritis-and-axial-spondyloarthritis 2025-05-19T11:08:38+01:00 0.5 https://www.ucb-usa.com/stories-media/UCB-U-S-News/detail/article/ucb-receives-us-fda-approval-for-bimzelxr-bimekizumab-bkzx-as-the-first-il-17a-and-il-17f-inhibitor-for-adults-with-moderate-to-severe-hidradenitis-suppurativa 2025-05-19T11:08:50+01:00 0.5 https://www.ucb-usa.com/stories-media/UCB-U-S-News/detail/article/closing-gaps-hs-care-through-community-engagement-and 2025-05-19T11:09:01+01:00 0.5 https://www.ucb-usa.com/stories-media/UCB-U-S-News/detail/article/ucb-presents-latest-scientific-research-in-epilepsy-at-american-epilepsy-society-annual-meeting 2025-05-19T11:09:10+01:00 0.5 https://www.ucb-usa.com/stories-media/UCB-U-S-News/detail/article/ucb-presents-new-data-on-impact-and-burden-of-epilepsy-at-2024-american-epilepsy-society-aes-meeting 2025-05-19T11:09:31+01:00 0.5 https://www.ucb-usa.com/stories-media/UCB-U-S-News/detail/article/charting-future-ucbs-2024-achievements-are-fueling-our-2025-ambitions 2025-10-22T18:55:46+01:00 0.5 https://www.ucb-usa.com/stories-media/UCB-U-S-News/detail/article/ucb-announces-us-availability-of-320-mg2-ml-single-injection-administration-option-for-bimzelx-bimekizumab-bkzx 2025-05-19T11:11:03+01:00 0.5 https://www.ucb-usa.com/stories-media/UCB-U-S-News/detail/article/rare-disease-day-2025-elevating-lives-under-served-and 2025-05-19T11:11:43+01:00 0.5 https://www.ucb-usa.com/stories-media/UCB-U-S-News/detail/article/voices-value-supporting-people-impacted-rare-disease 2025-05-19T11:11:54+01:00 0.5 https://www.ucb-usa.com/stories-media/UCB-U-S-News/detail/article/providing-us-policy-actions-rare-disease 2025-05-19T11:14:11+01:00 0.5 https://www.ucb-usa.com/stories-media/UCB-U-S-News/detail/article/shining-light-resilience-honoring-black-history-month-0 2025-05-19T11:14:01+01:00 0.5 https://www.ucb-usa.com/stories-media/UCB-U-S-News/detail/article/beyond-diagnosis-embracing-humanity-behind-epilepsy-care 2025-05-19T11:13:46+01:00 0.5 https://www.ucb-usa.com/stories-media/UCB-U-S-News/detail/article/on-growth-path-a-decade-plus-strong-launch-execution-driving-company-growth 2025-05-19T11:12:40+01:00 0.5 https://www.ucb-usa.com/stories-media/UCB-U-S-News/detail/article/carecompass-transforming-care-journey-caregivers-and 2025-05-19T11:12:03+01:00 0.5 https://www.ucb-usa.com/stories-media/UCB-U-S-News/detail/article/voices-value-prioritizing-patients-now-and-future 2025-10-22T18:54:30+01:00 0.5 https://www.ucb-usa.com/stories-media/UCB-U-S-News/detail/article/bimzelxr-bimekizumab-bkzx-five-year-data-at-aad-2025-showed-sustained-skin-clearance-and-long-term-efficacy-in-moderate-to-severe-plaque-psoriasis 2025-05-19T11:12:14+01:00 0.5 https://www.ucb-usa.com/stories-media/UCB-U-S-News/detail/article/bimzelxr-bimekizumab-bkzx-two-year-data-at-aad-showed-potential-to-eliminate-draining-tunnels-in-hidradenitis-suppurativa-and-reduction-in-disease-burden 2025-05-19T11:12:22+01:00 0.5 https://www.ucb-usa.com/stories-media/UCB-U-S-News/detail/article/improving-dermatology-outcomes-timely-diagnosis-and-long 2025-05-19T11:12:32+01:00 0.5 https://www.ucb-usa.com/stories-media/UCB-U-S-News/detail/article/epilepsia-publishes-final-analysis-open-label-extension 2025-05-19T11:13:31+01:00 0.5 https://www.ucb-usa.com/stories-media/UCB-U-S-News/detail/article/new-data-on-investigational-therapy-for-thymidine-kinase-2-deficiency-presented-at-muscular-dystrophy-association-mda-2025-conference 2025-05-19T11:12:47+01:00 0.5 https://www.ucb-usa.com/stories-media/UCB-U-S-News/detail/article/ucbs-kassandra-watson-and-windy-wang-recognized 2025-06-17T12:26:45+01:00 0.5 https://www.ucb-usa.com/stories-media/UCB-U-S-News/detail/article/join-ucb-mgfa-national-patient-conference-and-visit-our 2025-05-19T11:13:03+01:00 0.5 https://www.ucb-usa.com/stories-media/UCB-U-S-News/detail/article/first-ucb-us-rare-disease-connect-neurology-rdcn-annual 2025-05-19T11:13:22+01:00 0.5 https://www.ucb-usa.com/stories-media/UCB-U-S-News/detail/article/ucb-presents-latest-research-across-leading-neurology-portfolio-at-american-academy-of-neurology-aan-meeting-2025 2025-05-19T11:13:38+01:00 0.5 https://www.ucb-usa.com/stories-media/UCB-U-S-News/detail/article/earth-day-2025-advancing-our-commitment-healthier-planet 2025-05-19T11:14:18+01:00 0.5 https://www.ucb-usa.com/stories-media/UCB-U-S-News/detail/article/partnering-patient-communities-advance-hs-awareness-and-0 2025-06-02T16:25:09+01:00 0.5 https://www.ucb-usa.com/stories-media/UCB-U-S-News/detail/article/resources-resilience-dravet-syndrome-awareness-month 2025-06-04T23:00:45+01:00 0.5 https://www.ucb-usa.com/stories-media/UCB-U-S-News/detail/article/bimzelxr-bimekizumab-bkzx-three-year-data-at-eular-2025-showed-lasting-efficacy-and-control-of-inflammation-in-psoriatic-arthritis-and-axial-spondyloarthritis 2025-06-11T16:57:51+01:00 0.5 https://www.ucb-usa.com/stories-media/UCB-U-S-News/detail/article/ucb-announces-major-us-investment-expand-biologics 2025-08-29T02:38:52+01:00 0.5 https://www.ucb-usa.com/stories-media/UCB-U-S-News/detail/article/inaugural-2025-ucb-us-myasthenia-gravis-scholarshiptm 2025-06-17T12:27:11+01:00 0.5 https://www.ucb-usa.com/stories-media/UCB-U-S-News/detail/article/tu-salud-tu-familia-generates-awareness-rare-diseases 2025-06-17T12:28:04+01:00 0.5 https://www.ucb-usa.com/stories-media/UCB-U-S-News/detail/article/ucb-presents-latest-thymidine-kinase-2-deficiency-tk2d-research-at-the-united-mitochondrial-disease-foundation-umdf-2025-conference 2025-06-20T12:05:17+01:00 0.5 https://www.ucb-usa.com/stories-media/UCB-U-S-News/detail/article/ucb-announces-positive-results-gemz-phase-3-study 2025-06-27T12:01:19+01:00 0.5 https://www.ucb-usa.com/stories-media/UCB-U-S-News/detail/article/building-talent-shaping-futures-why-interns-matter 2025-07-31T00:05:24+01:00 0.5 https://www.ucb-usa.com/stories-media/UCB-U-S-News/detail/article/strength-connection-role-supportive-networks-psoriatic 2025-07-31T15:25:42+01:00 0.5 https://www.ucb-usa.com/stories-media/UCB-U-S-News/detail/article/beyond-awareness-uniting-brighter-future-hs-summit 2025-08-01T22:56:31+01:00 0.5 https://www.ucb-usa.com/stories-media/UCB-U-S-News/detail/article/ucbs-hs-summit-united-patients-and-experts-to-drive-progress-in-hidradenitis-suppurativa-awareness-and-treatment 2025-08-05T13:01:51+01:00 0.5 https://www.ucb-usa.com/stories-media/UCB-U-S-News/detail/article/our-growth-helps-elevate-patient-lives 2025-08-13T15:26:17+01:00 0.5 https://www.ucb-usa.com/stories-media/UCB-U-S-News/detail/article/decades-dedication-ucbs-ongoing-commitment-epilepsy 2025-11-08T02:32:38+00:00 0.5 https://www.ucb-usa.com/stories-media/UCB-U-S-News/detail/article/sniff-saves-honoring-service-dogs-awareness-month 2025-09-03T18:13:06+01:00 0.5 https://www.ucb-usa.com/stories-media/UCB-U-S-News/detail/article/profound-impact-lives-people-living-thymidine-kinase-2 2025-09-08T20:53:56+01:00 0.5 https://www.ucb-usa.com/stories-media/UCB-U-S-News/detail/article/gen-z-and-millennial-patients-find-rheum-improvement 2025-09-10T12:16:55+01:00 0.5 https://www.ucb-usa.com/stories-media/UCB-U-S-News/detail/article/gen-z-and-millennial-patients-with-chronic-rheumatic-diseases-are-opening-up-to-raise-awareness-for-improved-care 2025-09-10T12:16:28+01:00 0.5 https://www.ucb-usa.com/stories-media/UCB-U-S-News/detail/article/bimzelxr-bimekizumab-bkzx-data-moderate-severe-plaque-psoriasis-at-eadv-showed-complete-skin-clearance-sustained-over-four-years 2025-09-17T16:24:46+01:00 0.5 https://www.ucb-usa.com/stories-media/UCB-U-S-News/detail/article/bimzelxr-bimekizumab-bkzx-new-three-year-data-in-hidradenitis-suppurativa-at-eadv-showed-sustained-symptom-relief-across-multiple-clinical-endpoints 2025-09-17T16:51:36+01:00 0.5 https://www.ucb-usa.com/stories-media/UCB-U-S-News/detail/article/bandages-bravery-hs-patients-command-times-square 2025-10-03T14:32:24+01:00 0.5 https://www.ucb-usa.com/stories-media/UCB-U-S-News/detail/article/results-published-in-neurology-highlight-a-95-reduction-in-risk-of-death-with-pyrimidine-nucleostide-therapy-in-patients-with-thymidine-kinase-2-deficiency-tk2d 2025-10-13T12:18:44+01:00 0.5 https://www.ucb-usa.com/stories-media/UCB-U-S-News/detail/article/final-analysis-of-open-label-extension-ole-study-of-fintepla-fenfluramine-in-lennox-gastaut-syndrome-published-in-epilepsy-and-behavior. 2025-10-14T12:02:02+01:00 0.5 https://www.ucb-usa.com/stories-media/UCB-U-S-News/detail/article/innovative-collaborations-enhancing-epilepsy-care-through 2025-10-16T17:52:35+01:00 0.5 https://www.ucb-usa.com/stories-media/UCB-U-S-News/detail/article/multidisciplinary-collaboration-future-patient-centered 2025-10-24T12:51:36+01:00 0.5 https://www.ucb-usa.com/stories-media/UCB-U-S-News/detail/article/generalized-myasthenia-gravis-management-shared-decision 2025-10-27T15:05:25+00:00 0.5 https://www.ucb-usa.com/stories-media/UCB-U-S-News/detail/article/bimzelxr-bimekizumab-bkzx-three-year-rheumatology-data-at-acr-2025-demonstrated-sustained-inflammation-control-in-psoriatic-arthritis-and-axial-spondyloarthritis 2025-10-25T16:39:13+01:00 0.5 https://www.ucb-usa.com/stories-media/UCB-U-S-News/detail/article/ucb-to-unveil-new-data-for-rystiggo-rozanolixizumab-noli-and-and-zilbrysq-zilucoplan-for-gmg-at-the-2025-aanem-annual-meeting-and-mgfa-scientific-session 2025-10-29T11:27:01+00:00 0.5 https://www.ucb-usa.com/stories-media/UCB-U-S-News/detail/article/ucb-opens-applications-for-2026-ucb-myasthenia-gravis-scholarship 2025-10-30T19:55:29+00:00 0.5 https://www.ucb-usa.com/stories-media/UCB-U-S-News/detail/article/bimzelx-bimekizumab-bkzx-data-in-hidradenitis-suppurativa-showed-improvements-in-pain-and-resolution-of-draining-tunnels-sustained-to-three-years 2025-10-31T16:59:33+00:00 0.5 https://www.ucb-usa.com/stories-media/UCB-U-S-News/detail/article/redefining-hidradenitis-suppurativa-hs-care-through 2025-10-31T16:59:56+00:00 0.5 https://www.ucb-usa.com/stories-media/UCB-U-S-News/detail/article/us-fda-approves-kygevvi-doxecitine-and-doxribtimine-the-first-and-only-treatment-for-adults-and-children-living-with-thymidine-kinase-2-deficiency-tk2d 2026-03-10T13:56:27+00:00 0.5 https://www.ucb-usa.com/stories-media/UCB-U-S-News/detail/article/elevating-lives-people-impacted-thymidine-kinase-2 2025-11-13T21:21:43+00:00 0.5 https://www.ucb-usa.com/stories-media/UCB-U-S-News/detail/article/when-every-second-matters 2025-11-14T21:36:35+00:00 0.5 https://www.ucb-usa.com/stories-media/UCB-U-S-News/detail/article/ucb-shares-leading-scientific-research-and-advances-at-american-epilepsy-society-annual-meeting 2025-12-04T12:27:42+00:00 0.5 https://www.ucb-usa.com/stories-media/UCB-U-S-News/detail/article/bridging-strategy-and-innovation-leadership-action 2025-12-04T15:32:41+00:00 0.5 https://www.ucb-usa.com/stories-media/UCB-U-S-News/detail/article/ucb-presents-positive-results-for-gemz-phase-3-study-at-aes-showing-fenfluramine-significantly-reduced-countable-motor-seizure-frequency-in-cdkl5-deficiency-disorder 2025-12-09T15:25:19+00:00 0.5 https://www.ucb-usa.com/stories-media/UCB-U-S-News/detail/article/more-medicine-ucbs-holistic-approach-supporting-mg 2026-02-04T19:28:40+00:00 0.5 https://www.ucb-usa.com/stories-media/UCB-U-S-News/detail/article/innovation-equals-access-how-ucb-delivered-patients-2025 2026-03-10T13:58:28+00:00 0.5 https://www.ucb-usa.com/stories-media/UCB-U-S-News/detail/article/bimzelxr-bimekizumab-superior-to-skyrizir-risankizumab-in-be-bold-first-head-to-head-study-in-active-psoriatic-arthritis-psa-to-demonstrate-superiority-in-acr50 2026-03-11T11:04:15+00:00 0.5 https://www.ucb-usa.com/stories-media/UCB-U-S-News/detail/article/3-in-3-advancing-hope-for-rare-and-ultra-rare-disease-communities-one-innovation-at-a-time 2026-03-16T14:14:50+00:00 0.5 https://www.ucb-usa.com/stories-media/UCB-U-S-News/detail/article/ucb-selects-georgia-for-new-us-biologics-manufacturing-facility 2026-03-24T18:47:13+00:00 0.5 https://www.ucb-usa.com/stories-media/UCB-U-S-News/detail/article/ucb-announces-new-bimzelxr-bimekizumab-bkzx-data-at-aad-showing-durable-symptom-control-throughout-three-years-in-hidradenitis-suppurativa 2026-03-27T13:50:44+00:00 0.5 https://www.ucb-usa.com/stories-media/UCB-U-S-News/detail/article/ucb-presents-new-bimzelxr-bimekizumab-bkzx-data-at-aad-demonstrating-high-rates-of-durable-and-complete-skin-clearance-in-moderate-to-severe-plaque-psoriasis 2026-03-27T13:49:54+00:00 0.5 https://www.ucb-usa.com/stories-media/UCB-U-S-News/detail/article/evolving-expectations-immunologic-disease-our-work-those 2026-03-27T15:48:16+00:00 0.5